Blog
RSS FeedPosted by Michael Wonder on 21 Mar 2019
Kentucky launches probe into drug overcharges by pharmacy benefit managers
22 March 2019 - Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that ...
Posted by Michael Wonder on 21 Mar 2019
Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates
20 March 2019 - RetireSafe, a Washington-based advocacy group with ties to the drug industry, appears to be behind a ...
Posted by Michael Wonder on 19 Mar 2019
A drug pricing mystery: Who’s behind all the outrage over rebates?
19 March 2019 - The Department of Health and Human Services has already received 18,000 comments on its proposal to end ...
Posted by Michael Wonder on 13 Mar 2019
Drug price watchdog ICER dives into Trump fueled pharma rebate debate
13 March 2019 - With public and political winds blowing in the same direction, significant reform of the complicated U.S. ...
Posted by Michael Wonder on 13 Mar 2019
UnitedHealth expands drug rebate program to consumers
12 March 2019 - UnitedHealth, the country’s largest health insurer, said Tuesday it would expand a program that passes drug ...
Posted by Michael Wonder on 12 Mar 2019
Institute for Clinical and Economic Review publishes white paper on alternative models for pharmaceutical rebates
12 March 2019 - Paper explores how reforming or eliminating rebates may affect drug pricing, patient access, and incentives for future ...
Posted by Michael Wonder on 07 Mar 2019
Gottlieb: drug rebates not benefiting sicker patients
6 March 2019 - Food and Drug Administration (FDA) Commissioner Scott Gottlieb said Wednesday that drug discounts known as rebates ...
Posted by Michael Wonder on 06 Mar 2019
Prescription drugs—list price, net price, and the rebate caught in the middle
6 March 2019 - Pharmacy benefit managers, such as Express Scripts, CVS Caremark, and Optum Rx, are some of the ...
Posted by Michael Wonder on 04 Mar 2019
Regulatory information – adjusted fees for applications to EMA from 1 April 2019
1 March 2019 - The EMA reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for ...
Posted by Michael Wonder on 28 Feb 2019
Rebates and drug costs: what the new proposal would mean
28 February 2019 - The Trump administration is trying in myriad ways to answer demands from consumers for lower prescription ...
Posted by Michael Wonder on 26 Feb 2019
A small drug maker settles charges for paying others to submit its FDA applications
26 February 2019 - A small drug maker was fined $4 million for striking deals with two tiny companies to ...
Posted by Michael Wonder on 25 Feb 2019
Prescriptions to rise to £9 from April
25 February 2019 - The government has announced another rise in prescription costs for medicines dispensed on the NHS in ...
Posted by Michael Wonder on 09 Feb 2019
Novartis CEO lauds Trump administration plan to overhaul rebates
7 February 2019 - Novartis AG Chief Executive Vas Narasimhan said his company's prescription drug prices have been "flat to ...
Posted by Michael Wonder on 06 Feb 2019
More affordable medicines for all Australians
6 February 2019 - The Pharmacy Guild of Australia wants to see more affordable medicines for all Australians, and the ...
Posted by Michael Wonder on 04 Feb 2019
Rebates to the dustbin of history?
4 February 2019 - The Trump Administration has proposed eliminating certain rebates drug manufacturers pay pharmacy benefit managers and insurers. ...